Gujarat Fluorochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 6:10 am

Competitors of Gujarat Fluorochemicals Ltd

All Competitor Stocks of Gujarat Fluorochemicals Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:05 am

Below is a detailed analysis of the quarterly data for Gujarat Fluorochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,225.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,148.00 Cr. (Dec 2024) to 1,225.00 Cr., marking an increase of 77.00 Cr..
• For Expenses, as of Mar 2025, the value is 919.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 854.00 Cr. (Dec 2024) to 919.00 Cr., marking an increase of 65.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 306.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Dec 2024) to 306.00 Cr., marking an increase of 12.00 Cr..
• For OPM %, as of Mar 2025, the value is 25.00%. The value appears to be declining and may need further review. It has decreased from 26.00% (Dec 2024) to 25.00%, marking a decrease of 1.00%.
• For Other Income, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Dec 2024) to 26.00 Cr., marking an increase of 12.00 Cr..
• For Interest, as of Mar 2025, the value is 26.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 42.00 Cr. (Dec 2024) to 26.00 Cr., marking a decrease of 16.00 Cr..
• For Depreciation, as of Mar 2025, the value is 89.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 91.00 Cr. (Dec 2024) to 89.00 Cr., marking a decrease of 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 217.00 Cr.. The value appears strong and on an upward trend. It has increased from 175.00 Cr. (Dec 2024) to 217.00 Cr., marking an increase of 42.00 Cr..
• For Tax %, as of Mar 2025, the value is 12.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Dec 2024) to 12.00%, marking a decrease of 16.00%.
• For Net Profit, as of Mar 2025, the value is 191.00 Cr.. The value appears strong and on an upward trend. It has increased from 126.00 Cr. (Dec 2024) to 191.00 Cr., marking an increase of 65.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 17.39. The value appears strong and on an upward trend. It has increased from 11.47 (Dec 2024) to 17.39, marking an increase of 5.92.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:32 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 3:25 pm

Below is a detailed analysis of the balance sheet data for Gujarat Fluorochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,925.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 5,925.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 2,096.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2,096.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,201.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1,201.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). It has decreased from 9,233.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 9,233.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,264.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 4,264.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,128.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1,128.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,840.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 3,840.00 Cr..
• For Total Assets, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,233.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 9,233.00 Cr..

Reserves and Borrowings are well balanced.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Gujarat Fluorochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.44 (Mar 23) to 39.60, marking a decrease of 80.84.
• For Diluted EPS (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.44 (Mar 23) to 39.60, marking a decrease of 80.84.
• For Cash EPS (Rs.), as of Mar 24, the value is 65.64. This value is within the healthy range. It has decreased from 141.93 (Mar 23) to 65.64, marking a decrease of 76.29.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 540.40. It has increased from 502.57 (Mar 23) to 540.40, marking an increase of 37.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 540.40. It has increased from 502.57 (Mar 23) to 540.40, marking an increase of 37.83.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 389.70. It has decreased from 517.49 (Mar 23) to 389.70, marking a decrease of 127.79.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 92.33. This value is within the healthy range. It has decreased from 194.59 (Mar 23) to 92.33, marking a decrease of 102.26.
• For PBIT / Share (Rs.), as of Mar 24, the value is 66.29. This value is within the healthy range. It has decreased from 173.10 (Mar 23) to 66.29, marking a decrease of 106.81.
• For PBT / Share (Rs.), as of Mar 24, the value is 54.17. This value is within the healthy range. It has decreased from 162.47 (Mar 23) to 54.17, marking a decrease of 108.30.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.44 (Mar 23) to 39.60, marking a decrease of 80.84.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.97 (Mar 23) to 39.60, marking a decrease of 81.37.
• For PBDIT Margin (%), as of Mar 24, the value is 23.69. This value is within the healthy range. It has decreased from 37.60 (Mar 23) to 23.69, marking a decrease of 13.91.
• For PBIT Margin (%), as of Mar 24, the value is 17.01. This value is within the healthy range. It has decreased from 33.45 (Mar 23) to 17.01, marking a decrease of 16.44.
• For PBT Margin (%), as of Mar 24, the value is 13.90. This value is within the healthy range. It has decreased from 31.39 (Mar 23) to 13.90, marking a decrease of 17.49.
• For Net Profit Margin (%), as of Mar 24, the value is 10.16. This value exceeds the healthy maximum of 10. It has decreased from 23.27 (Mar 23) to 10.16, marking a decrease of 13.11.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.16. This value is within the healthy range. It has decreased from 23.37 (Mar 23) to 10.16, marking a decrease of 13.21.
• For Return on Networth / Equity (%), as of Mar 24, the value is 7.32. This value is below the healthy minimum of 15. It has decreased from 24.06 (Mar 23) to 7.32, marking a decrease of 16.74.
• For Return on Capital Employeed (%), as of Mar 24, the value is 10.81. This value is within the healthy range. It has decreased from 31.52 (Mar 23) to 10.81, marking a decrease of 20.71.
• For Return On Assets (%), as of Mar 24, the value is 4.71. This value is below the healthy minimum of 5. It has decreased from 15.87 (Mar 23) to 4.71, marking a decrease of 11.16.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 23) to 0.06, marking an increase of 0.03.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.33. This value is within the healthy range. It has increased from 0.26 (Mar 23) to 0.33, marking an increase of 0.07.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.48. It has decreased from 0.74 (Mar 23) to 0.48, marking a decrease of 0.26.
• For Current Ratio (X), as of Mar 24, the value is 1.36. This value is below the healthy minimum of 1.5. It has decreased from 1.50 (Mar 23) to 1.36, marking a decrease of 0.14.
• For Quick Ratio (X), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.86 (Mar 23) to 0.73, marking a decrease of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.52. This value is below the healthy minimum of 4. It has decreased from 2.61 (Mar 23) to 1.52, marking a decrease of 1.09.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 5.05. This value is below the healthy minimum of 20. It has increased from 3.30 (Mar 23) to 5.05, marking an increase of 1.75.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.04. This value is below the healthy minimum of 20. It has increased from 2.80 (Mar 23) to 3.04, marking an increase of 0.24.
• For Earning Retention Ratio (%), as of Mar 24, the value is 94.95. This value exceeds the healthy maximum of 70. It has decreased from 96.70 (Mar 23) to 94.95, marking a decrease of 1.75.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.96. This value exceeds the healthy maximum of 70. It has decreased from 97.20 (Mar 23) to 96.96, marking a decrease of 0.24.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 7.62. This value is within the healthy range. It has decreased from 18.30 (Mar 23) to 7.62, marking a decrease of 10.68.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.27. This value is within the healthy range. It has decreased from 12.33 (Mar 23) to 4.27, marking a decrease of 8.06.
• For Enterprise Value (Cr.), as of Mar 24, the value is 35,822.28. It has increased from 34,443.07 (Mar 23) to 35,822.28, marking an increase of 1,379.21.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.37. This value exceeds the healthy maximum of 3. It has increased from 6.06 (Mar 23) to 8.37, marking an increase of 2.31.
• For EV / EBITDA (X), as of Mar 24, the value is 35.32. This value exceeds the healthy maximum of 15. It has increased from 16.11 (Mar 23) to 35.32, marking an increase of 19.21.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 5.83 (Mar 23) to 7.95, marking an increase of 2.12.
• For Retention Ratios (%), as of Mar 24, the value is 94.94. This value exceeds the healthy maximum of 70. It has decreased from 96.69 (Mar 23) to 94.94, marking a decrease of 1.75.
• For Price / BV (X), as of Mar 24, the value is 5.73. This value exceeds the healthy maximum of 3. It has decreased from 6.00 (Mar 23) to 5.73, marking a decrease of 0.27.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 5.83 (Mar 23) to 7.95, marking an increase of 2.12.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.01, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Strength and Weakness